{"id":"https://openalex.org/W16320915","doi":null,"title":"Clobetasol propionate for psoriasis: are ointments really more potent?","display_name":"Clobetasol propionate for psoriasis: are ointments really more potent?","publication_year":2006,"publication_date":"2006-06-01","ids":{"openalex":"https://openalex.org/W16320915","mag":"16320915","pmid":"https://pubmed.ncbi.nlm.nih.gov/16774104"},"language":"en","primary_location":{"id":"pmid:16774104","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16774104","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019724990","display_name":"Lindsey Warino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsey Warino","raw_affiliation_strings":["Ohio State University College of Medicine, School of Public Health, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University College of Medicine, School of Public Health, Columbus, OH, USA","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015605411","display_name":"Rajesh Balkrishnan","orcid":"https://orcid.org/0000-0001-9363-9257","observed_orcids":["https://orcid.org/0000-0001-9363-9257"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajesh Balkrishnan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006964107","display_name":"Steven R. Feldman","orcid":"https://orcid.org/0000-0002-0090-6289","observed_orcids":["https://orcid.org/0000-0002-0090-6289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven R Feldman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0092,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.73547903,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"5","issue":"6","first_page":"527","last_page":"32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clobetasol-propionate","display_name":"clobetasol propionate","score":1.0},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.9750000238418579},{"id":"https://openalex.org/keywords/ointment-vehicles","display_name":"ointment vehicles","score":0.7559999823570251},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6890000104904175},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.7540000081062317},{"id":"https://openalex.org/keywords/vehicle-comparison","display_name":"vehicle comparison","score":0.38499999046325684},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.37299999594688416}],"concepts":[{"id":"https://openalex.org/C2776110085","wikidata":"https://www.wikidata.org/wiki/Q421637","display_name":"Clobetasol propionate","level":3,"score":0.9509801864624023},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9265236854553223},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8805078268051147},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7918804883956909},{"id":"https://openalex.org/C2780986958","wikidata":"https://www.wikidata.org/wiki/Q1871151","display_name":"Lotion","level":2,"score":0.6350984573364258},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.45044201612472534},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.412826269865036},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2283233404159546},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13796740770339966},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002990","descriptor_name":"Clobetasol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002990","descriptor_name":"Clobetasol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002990","descriptor_name":"Clobetasol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004643","descriptor_name":"Emollients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009824","descriptor_name":"Ointments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16774104","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16774104","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:16320915","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16774104","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1612234481","https://openalex.org/W92547266","https://openalex.org/W2133146214","https://openalex.org/W2240108040","https://openalex.org/W2027913348","https://openalex.org/W4233560438","https://openalex.org/W4251259111","https://openalex.org/W2073269393","https://openalex.org/W2355967663","https://openalex.org/W2379693379"],"abstract_inverted_index":{"BACKGROUND:":[0],"Clobetasol":[1,158],"propionate":[2,73,79,159],"is":[3,18,160],"the":[4,13,23,63,68,82,102,117,146],"most":[5],"common":[6],"topical":[7],"therapy":[8],"used":[9],"for":[10,38,145,165],"psoriasis":[11,99],"in":[12,81,121,175,184],"US.":[14],"Conventional":[15],"dermatologic":[16],"wisdom":[17],"that":[19,100,106,115,133],"ointment":[20,46,74],"preparations":[21,80,168,174],"provide":[22],"highest":[24],"potency":[25,70],"(due":[26],"to":[27,47,58,76,143,172,191,198],"their":[28],"occlusive":[29],"nature":[30],"and":[31,34,55,66,92,131,155],"moisturizing":[32],"ability)":[33],"are":[35,188],"best":[36,197],"suited":[37],"psoriasis.":[39,85,166],"However,":[40],"patients":[41,202],"often":[42],"find":[43,203],"application":[44],"of":[45,71,84,98,104],"be":[48,196],"messy,":[49],"raising":[50],"concerns":[51],"about":[52],"both":[53],"short-term":[54],"long-term":[56],"adherence":[57],"treatment.":[59],"This":[60],"article":[61],"reviews":[62],"current":[64],"literature":[65,87],"assesses":[67],"relative":[69],"clobetasol":[72,78],"compared":[75],"other":[77,173],"treatment":[83,164],"Relevant":[86],"was":[88],"identified":[89],"by":[90],"PubMed":[91],"Google":[93],"searches.":[94],"We":[95,125],"included":[96],"studies":[97,114,127],"reported":[101,116],"percentage":[103],"subjects":[105],"achieved":[107],"desired":[108],"efficacy":[109,171],"endpoints,":[110],"as":[111,113],"well":[112],"subjects'":[118],"mean":[119],"change":[120],"symptoms":[122],"from":[123,141],"baseline.":[124],"excluded":[126],"conducted":[128],"before":[129],"1980":[130],"those":[132],"allowed":[134],"concomitant":[135],"treatments.":[136],"OBSERVATIONS:":[137],"Efficacy":[138],"rates":[139],"ranged":[140],"17%":[142],"80%":[144],"different":[147],"vehicles:":[148],"ointment,":[149],"solution,":[150],"foam,":[151],"cream,":[152],"lotion,":[153],"shampoo,":[154],"emollient.":[156],"CONCLUSIONS:":[157],"a":[161,182],"very":[162],"effective":[163],"Ointment":[167],"have":[169],"similar":[170],"clinical":[176,180],"trial":[177],"situations.":[178],"In":[179],"practice,":[181],"situation":[183],"which":[185],"patient":[186],"preferences":[187],"more":[189],"likely":[190],"affect":[192],"compliance,":[193],"it":[194],"may":[195],"choose":[199],"whichever":[200],"vehicle":[201],"preferable.":[204]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}